Umoja Biopharma
Seattle, WA
Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer. The company's treatment approach retools a patient’s immune system in vivo to direct potent anti-cancer immune cells to a patient’s tumor, augmenting the body’s natural mechanisms for fighting cancer.
umoja-biopharma.comCompany Details
Founded
- 2019
Employees
- Between 100 - 500 employees
Raised
- $263,000,000
Headquarters Location
- Seattle, WA
Public
- No
Acquired
- No
CEO
Andrew Scharenberg
Founders
- Michael JensenPhilip LowAndrew ScharenbergRyan Crisman
Company Collections
These are collections Umoja Biopharma is a part of. Click on the collection name to view similar companies.